Hospital Universitario La Fe -ko ikertzaileekin lankidetzan egindako argitalpenak (6)

2022

  1. Clinical, histological, and genetic features of 25 patients with autosomal dominant progressive external ophthalmoplegia (Ad-PEO)/PEO-plus due to TWNK mutations

    Journal of Clinical Medicine, Vol. 11, Núm. 1

2021

  1. Normal tissue content impact on the GBM molecular classification

    Briefings in bioinformatics, Vol. 22, Núm. 3

2020

  1. Clinical, pathological and genetic spectrum in 89 cases of mitochondrial progressive external ophthalmoplegia

    Journal of Medical Genetics, Vol. 57, Núm. 9, pp. 643-646

2018

  1. Correction to: SEOM clinical guideline of diagnosis and management of low-grade glioma (2017) (Clinical and Translational Oncology, (2018), 20, 1, (3-15), 10.1007/s12094-017-1790-3)

    Clinical and Translational Oncology

  2. SEOM clinical guideline of diagnosis and management of low-grade glioma (2017)

    Clinical and Translational Oncology, Vol. 20, Núm. 1, pp. 3-15

2017

  1. Phase II trial of dacomitinib, a pan-human EGFR tyrosine kinase inhibitor, in recurrent glioblastoma patients with EGFR amplification

    Neuro-Oncology, Vol. 19, Núm. 11, pp. 1522-1531